Holen Sie sich die Stockscreener-App
9.48
3.61%
0.33
Handel nachbörslich:
9.48
Schlusskurs vom Vortag:
$9.15
Offen:
$9.27
24-Stunden-Volumen:
1.43M
Relative Volume:
1.00
Marktkapitalisierung:
$1.28B
Einnahmen:
$3.26B
Nettoeinkommen (Verlust:
$-214.34M
KGV:
-5.7455
EPS:
-1.65
Netto-Cashflow:
$229.32M
1W Leistung:
+6.16%
1M Leistung:
+12.99%
6M Leistung:
-6.78%
1J Leistung:
-14.59%
1-Tages-Spanne:
$9.17
$9.64
1-Wochen-Bereich:
$8.78
$9.64
52-Wochen-Spanne:
$7.105
$11.90
Adapthealth Corp Stock (AHCO) Company Profile
Firmenname
Adapthealth Corp
Sektor
Branche
Telefon
610-424-4515
Adresse
555 EAST NORTH LANE, CONSHOHOCKEN, PA
Vergleichen Sie AHCO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
AHCO
Adapthealth Corp
|
9.48 | 1.21B | 3.26B | -214.34M | 229.32M | -1.65 |
|
ABT
Abbott Laboratories
|
125.73 | 228.77B | 43.11B | 13.98B | 6.66B | 7.98 |
|
BSX
Boston Scientific Corp
|
103.16 | 153.09B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
395.15 | 149.27B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
91.65 | 114.31B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
76.30 | 45.06B | 5.54B | 4.18B | 623.10M | 7.00 |
Adapthealth Corp Stock (AHCO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-01-08 | Herabstufung | Jefferies | Buy → Hold |
| 2023-11-08 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2023-05-10 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2023-05-10 | Herabstufung | Stifel | Buy → Hold |
| 2023-05-09 | Herabstufung | BofA Securities | Buy → Neutral |
| 2021-09-27 | Eingeleitet | SVB Leerink | Outperform |
| 2021-07-14 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2021-04-13 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2021-03-18 | Eingeleitet | Truist | Buy |
| 2021-01-26 | Eingeleitet | BofA Securities | Buy |
| 2020-12-10 | Eingeleitet | UBS | Buy |
| 2020-08-10 | Eingeleitet | Canaccord Genuity | Buy |
| 2020-07-01 | Fortgesetzt | SVB Leerink | Outperform |
| 2020-06-09 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2020-01-31 | Eingeleitet | Stifel | Buy |
| 2020-01-07 | Eingeleitet | Jefferies | Buy |
| 2019-12-11 | Eingeleitet | SVB Leerink | Outperform |
| 2019-12-10 | Eingeleitet | Deutsche Bank | Buy |
Alle ansehen
Adapthealth Corp Aktie (AHCO) Neueste Nachrichten
What drives AdaptHealth Corp. stock priceRobust investment performance - jammulinksnews.com
Is AdaptHealth Corp. a good long term investmentHigh-margin investment plays - jammulinksnews.com
Briefly: AdaptHealth to Discuss Financial Results; AARC Seeking Zenith Award Nominees - HME Business
AdaptHealth to Announce Q2 2025 Financial Results on August 5 - MSN
AdaptHealth Corp. Stock Analysis and ForecastOverwhelming profit margins - jammulinksnews.com
What analysts say about AdaptHealth Corp. stockBreakthrough stock performance - jammulinksnews.com
Truist Financial Remains Bullish on AdaptHealth (AHCO) - MSN
4 'Strong Buy' Stocks Under $10 with Up to 55% Upside - Investing.com
AdaptHealth Corp. Announces Second Quarter 2025 Earnings Release Date and Conference Call - Business Wire
(AHCO) Pivots Trading Plans and Risk Controls - news.stocktradersdaily.com
Is the Options Market Predicting a Spike in AdaptHealth Stock? - Nasdaq
AdaptHealth Sells Infusion Assets, Advances Debt Reduction Strategy - MSN
AdaptHealth’s SWOT analysis: stock resilience amid market challenges - Investing.com
AdaptHealth Corp.: Divesting for Survival and Shareholder Value - AInvest
Important Notice to Long-Term Shareholders of AdaptHealth Corp. (NASDAQ: AHCO); CorMedix Inc. (NASDAQ: CRMD); Napco Security Technologies, Inc. (NASDAQ: NSSC); and Virtu Financial Inc. (NYSE: VIRT): Grabar Law Office is Investigating Claims on - GlobeNewswire
Important Notice to Long-Term Shareholders of AdaptHealth Corp. (NASDAQ: AHCO); CorMedix Inc. ... - Bluefield Daily Telegraph
AdaptHealth stock maintains Buy rating at Truist after infusion asset sale - Investing.com Canada
AdaptHealth Latest Strategic Move: $65M Debt Slash from Healthcare Asset Sale Signals Major Restructuring - Stock Titan
AdaptHealth Corp.(NasdaqCM:AHCO) dropped from Russell Small Cap Comp Growth Index - MarketScreener
AdaptHealth Completes Infusion Asset Sale; 2025 Outlook Updated - MarketScreener
Truist reiterates buy rating on AdaptHealth stock citing market position - Investing.com
Is AdaptHealth Corp. overvalued or undervalued? - MarketsMojo
AdaptHealth Approves Key Proposals at Annual Meeting - TipRanks
AdaptHealth's (NASDAQ:AHCO) Returns On Capital Not Reflecting Well On The Business - Yahoo Finance
AdaptHealth Q1 Net Loss Widens as Revenue Drops - MarketScreener
Two Sigma Investments LP Trims Holdings in AdaptHealth Corp. (NASDAQ:AHCO) - Defense World
Nuveen Asset Management LLC Raises Stake in AdaptHealth Corp. (NASDAQ:AHCO) - Defense World
AdaptHealth At A Crossroads: Automation, Integration, And The Future Of Home Care - Seeking Alpha
Where are the Opportunities in (AHCO) - news.stocktradersdaily.com
BNP Paribas Financial Markets Takes $229,000 Position in AdaptHealth Corp. (NASDAQ:AHCO) - Defense World
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Raises Stock Holdings in AdaptHealth Corp. (NASDAQ:AHCO) - Defense World
Deutsche Bank AG Grows Stock Position in AdaptHealth Corp. (NASDAQ:AHCO) - Defense World
AdaptHealth Corp. (NASDAQ:AHCO) Shares Bought by Janus Henderson Group PLC - Defense World
Ameriprise Financial Inc. Buys 65,606 Shares of AdaptHealth Corp. (NASDAQ:AHCO) - Defense World
Winners And Losers Of Q3: AdaptHealth (NASDAQ:AHCO) Vs The Rest Of The Senior Health, Home Health & Hospice Stocks - The Globe and Mail
D. E. Shaw & Co. Inc. Sells 301,092 Shares of AdaptHealth Corp. (NASDAQ:AHCO) - Defense World
Deadline Approaching for Receiving Share of AdaptHealth Corp. f/k/a DFB Healthcare Acquisitions Corp. (AHCO) RecoveryContact Levi & Korsinsky, LLP for Further Details - ACCESS Newswire
AdaptHealth to Join RBCCM Global Healthcare Conference with Fireside Chat - MSN
Adapthealth at RBC Conference: Strategic Moves and Challenges - Investing.com Australia
Adapthealth revises 2025 revenue guidance to $3.18B-$3.32B amid asset sales and operational improvements - MSN
AdaptHealth Reports First Quarter 2025 Financial Results, Updates Guidance - MSN
AdaptHealth’s SWOT analysis: stock faces challenges amid diabetes sector recovery - Investing.com India
Finanzdaten der Adapthealth Corp-Aktie (AHCO)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.64%
0.34%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):